Main Session
Sep
29
SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials
240 - Replication-Competent Adenoviral Double-Suicide Therapy with fSRS in Progressive Glioblastoma (RAD-Gli): A Phase 1 Trial
Presenter(s)
Shyam Nyati, PhD - Henry Ford Health System, Detroit, MI